Birchview Capital as of March 31, 2022
Portfolio Holdings for Birchview Capital
Birchview Capital holds 63 positions in its portfolio as reported in the March 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bristol Myers Squibb (BMY) | 39.6 | $55M | 754k | 73.03 | |
| Neurocrine Biosciences (NBIX) | 6.0 | $8.4M | 89k | 93.75 | |
| Aziyo Biologics (ELUT) | 6.0 | $8.3M | 1.4M | 5.84 | |
| Quidel Corporation | 4.8 | $6.7M | 60k | 112.46 | |
| ACADIA Pharmaceuticals (ACAD) | 3.5 | $4.8M | 199k | 24.22 | |
| Foghorn Therapeutics (FHTX) | 3.2 | $4.5M | 294k | 15.23 | |
| Albireo Pharma | 2.4 | $3.4M | 113k | 29.83 | |
| Accelr8 Technology | 2.3 | $3.2M | 2.3M | 1.44 | |
| United Therapeutics Corporation (UTHR) | 2.3 | $3.2M | 18k | 179.39 | |
| Continental Resources | 1.7 | $2.4M | 39k | 61.32 | |
| Biogen Idec (BIIB) | 1.5 | $2.1M | 10k | 210.59 | |
| Biodesix (BDSX) | 1.5 | $2.1M | 1.3M | 1.69 | |
| Karyopharm Therapeutics | 1.4 | $2.0M | 269k | 7.37 | |
| Encana Corporation (OVV) | 1.3 | $1.8M | 34k | 54.06 | |
| Biohaven Pharmaceutical Holding | 1.2 | $1.7M | 14k | 118.57 | |
| Prothena Corp SHS (PRTA) | 1.1 | $1.5M | 42k | 36.57 | |
| Masimo Corporation (MASI) | 1.0 | $1.4M | 9.3k | 145.58 | |
| Alkermes SHS (ALKS) | 0.9 | $1.3M | 50k | 26.32 | |
| Harrow Health (HROW) | 0.9 | $1.2M | 180k | 6.82 | |
| Corcept Therapeutics Incorporated (CORT) | 0.8 | $1.1M | 50k | 22.52 | |
| Inhibrx | 0.8 | $1.1M | 50k | 22.28 | |
| Equitrans Midstream Corp (ETRN) | 0.8 | $1.1M | 133k | 8.44 | |
| Gossamer Bio (GOSS) | 0.8 | $1.1M | 129k | 8.68 | |
| Docgo (DCGO) | 0.7 | $1.0M | 110k | 9.25 | |
| Arvinas Ord (ARVN) | 0.7 | $1.0M | 15k | 67.33 | |
| Amarin Corp Spons Adr New | 0.7 | $987k | 300k | 3.29 | |
| Pioneer Natural Resources | 0.7 | $950k | 3.8k | 250.00 | |
| Cytokinetics (CYTK) | 0.7 | $920k | 25k | 36.80 | |
| ImmunoGen | 0.7 | $904k | 190k | 4.76 | |
| Protagonist Therapeutics (PTGX) | 0.6 | $900k | 38k | 23.68 | |
| Soleno Therapeutics | 0.6 | $820k | 3.7M | 0.22 | |
| Aveo Pharmaceuticals | 0.6 | $783k | 140k | 5.59 | |
| Contrafect | 0.5 | $730k | 200k | 3.65 | |
| Inari Medical Ord | 0.5 | $725k | 8.0k | 90.62 | |
| Nektar Therapeutics | 0.5 | $690k | 128k | 5.39 | |
| Irhythm Technologies (IRTC) | 0.5 | $630k | 4.0k | 157.50 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $610k | 12k | 50.83 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $590k | 40k | 14.75 | |
| 2seventy Bio | 0.4 | $586k | 34k | 17.07 | |
| Vanda Pharmaceuticals (VNDA) | 0.4 | $566k | 50k | 11.32 | |
| Chemocentryx | 0.4 | $501k | 20k | 25.05 | |
| Cullinan Oncology (CGEM) | 0.3 | $472k | 45k | 10.46 | |
| Silk Road Medical Inc Common | 0.3 | $413k | 10k | 41.30 | |
| Bluebird Bio | 0.3 | $407k | 84k | 4.85 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.3 | $369k | 8.0k | 46.12 | |
| Amicus Therapeutics (FOLD) | 0.3 | $360k | 38k | 9.47 | |
| Ventyx Biosciences (VTYX) | 0.2 | $339k | 25k | 13.56 | |
| Xencor (XNCR) | 0.2 | $328k | 12k | 26.67 | |
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $325k | 20k | 16.25 | |
| Stoke Therapeutics (STOK) | 0.2 | $316k | 15k | 21.07 | |
| G1 Therapeutics | 0.2 | $304k | 40k | 7.60 | |
| Kiniksa Pharmaceuticals | 0.2 | $298k | 30k | 9.93 | |
| Phreesia (PHR) | 0.2 | $264k | 10k | 26.40 | |
| Iveric Bio | 0.2 | $252k | 15k | 16.80 | |
| Turning Point Therapeutics I | 0.2 | $215k | 8.0k | 26.88 | |
| Inflarx Nv (IFRX) | 0.1 | $128k | 70k | 1.83 | |
| Angion Biomedica Corp | 0.1 | $115k | 54k | 2.11 | |
| Aspira Womens Health | 0.1 | $107k | 103k | 1.04 | |
| Laird Superfood (LSF) | 0.1 | $101k | 28k | 3.61 | |
| Yield10 Bioscience | 0.1 | $99k | 19k | 5.28 | |
| Sientra | 0.1 | $89k | 40k | 2.23 | |
| Concert Pharmaceuticals I equity | 0.0 | $67k | 20k | 3.35 | |
| Akebia Therapeutics (AKBA) | 0.0 | $14k | 20k | 0.70 |
